INTRODUCTION
============

The horse industry, which includes breeding, racing, and riding, comprises a large proportion of the tourism and leisure industry \[[@b1-ajas-31-3-309]\]. In this industry, the athletic performance of a racehorse is the most important factor. Thus, biological characters---such as genetic variation, gene expression, and metabolic patterns---that relate to athletic performance have been studied in regard to molecular breeding and biomarker screening \[[@b2-ajas-31-3-309]--[@b5-ajas-31-3-309]\]. Skeletal muscle in racehorses is directly responsible for athletic performance with numerous genes involved in the process \[[@b6-ajas-31-3-309]\]. Furthermore, the Thoroughbred is a widely used animal model in exercise physiology \[[@b7-ajas-31-3-309]\] because it has high proportion of skeletal muscle mass comprising over 55% of its total body mass \[[@b8-ajas-31-3-309]\]. However, due to a lack of data and phenotypes as well as to the complex genetic architecture usually underlying quantitative traits, research on the biological characteristics of Thoroughbreds remains a challenge \[[@b9-ajas-31-3-309]\].

Genetic association studies have found suitable DNA markers for race traits in horses using single-nucleotide polymorphisms (SNPs). Most research has focused on athletic performance traits, locomotion, i.e., gaits; racing performance; and energy production \[[@b10-ajas-31-3-309]\]. A variant of doublesex and mab-3 related transcription factor 3 is significantly associated with the ability to pace in Icelandic horses, and it appears to be necessary for horses in other breeds to perform alternate gaits \[[@b2-ajas-31-3-309]\]. In addition, two performance-associated sequence variants of exercise-related genes, e.g., myostatin (*MSTN*) and pyruvate dehydrogenase kinase 4 (*PDK4*) have been studied. Two SNPs, *MSTN* (g.66493737C/T) and *PDK4* (g.38973231 A/G), have been identified in relation to race performance, and *MSTN* (g.66493737C/T) has previously been shown to contribute to muscle hypertrophy in a range of mammalian species and racing ability in horses while *PDK4* (g.38973231 A/G) has been shown to contribute to weight advantage in terms of handicap rating \[[@b3-ajas-31-3-309],[@b4-ajas-31-3-309],[@b11-ajas-31-3-309]\]. Glucose utilization regulation is tightly controlled by the uptake of glucose by glucose transporters, the rate of glycolytic flux, and the conversion of pyruvate to acetyl-CoA in mitochondria via the catalytic function of the pyruvate dehydrogenase complex (PDC). The critical rate-limiting step in the oxidation of glucose is the regulation of the PDC assemblage, which is controlled by pyruvate dehydrogenase kinase (PDK). PDK blocks the formation of the PDC resulting in beta-oxidation of fatty acids to acetyl-CoA, which is the substrate for oxidative phosphorylation. The oxidation of fatty acids is highly efficient in generating ATP and is controlled by PDK4 expression in skeletal muscle during and after exercise \[[@b12-ajas-31-3-309]\].

In a previous study, we conducted RNA-sequencing of skeletal muscle genes from six Thoroughbred horses before and after exercise in which several differentially expressed genes (DEGs), i.e., Peroxisome proliferator activated receptor delta, adrenoceptor beta 2, and glutamate-cysteine ligase catalytic subunit (GCLC)/glutamate-cysteine ligase modifier subunit (*GCLM*), were identified and characterized further to reveal the gene expression pattern associated with leukocytes in various horse tissues and for exercise times \[[@b13-ajas-31-3-309]--[@b16-ajas-31-3-309]\]. In addition, we identified cell development-associated genes such as *ERRFI1*, which is induced by exercise, but these remain to be characterized.

*ERRFI1*, which is related to induction during the mid-G1 phase of the cell cycle, is considered an immediate early response gene that can be induced by a variety of external stimuli including growth factors, cytokines, and stress factors \[[@b17-ajas-31-3-309],[@b18-ajas-31-3-309]\]. Disruption of murine *ERRFI1* leads to excessive osteophyte formation due to the hyperproliferation and chondrocytic differentiation of mesenchymal progenitor cells. This causes a form of premature joint degeneration that closely resembles osteoarthritis \[[@b19-ajas-31-3-309]\]. There are no data explaining the correlation between ERRFI1 genetic variation and exercise.

In this study, we focused on the race performance-related characterization of *ERRFI1* in Thoroughbreds. The expression of *ERRFI1* was confirmed in muscles and leukocytes before and after exercise, and subsequently, the transcription factor (TF)-binding sites within the regulatory region of *ERRFI1* were predicted. In addition, we found a novel non-synonymous SNP (nsSNP) in this gene and analyzed the correlation between it and race performance traits. Taken together, our results may contribute to the development of a genetic marker for the evaluation of race performance and selective breeding.

MATERIALS AND METHODS
=====================

Experimental animals and phenotypes
-----------------------------------

Racehorse information and race records were compiled in 2009 from the Korea Racing Authority (KRA) homepage (<http://studbook.kra.co.kr/studbook.jsp>). The racehorses used in the analysis were born between 2001 and 2007 with 16 horses born in 2007, 52 horses born in 2006, 13 horses born in 2005, 6 horses born in 2004, 7 horses born in 2003, 3 horses born in 2002, and 2 horses born in 2001. Horses used for this study comprised 44 females, 32 gelding, and 23 males. The average racing index (RI) and highest starts percentile ranking (SPR) were recorded for each age. RI was obtained by comparing the average prize money obtained per race by a particular horse with that paid on average to other horses racing at that location with the same birthplace and age. An RI of 1 indicates that the horse obtained the average prize money; an RI of 2 indicates the horse obtained twice the average prize money; and an RI of 0.5 indicates the horse obtained half the average prize money. SPR is a method of comparing racehorses based on the horse's class performance index (CPI) value and is expressed as a percentile with 100 being the highest and 0 the lowest. Thus, an SPR of 100 indicates the highest grade racehorse and an SPR of 0 indicates the lowest grade racehorse. CPI is an index calculated by comparing the total prize money of a given racehorse obtained for 1 year to the average prize money obtained by all racehorses for 1 year with a CPI of 1 being average. Speed Index was the average score of winners in the last three years by distance. Index was set at 100 and it is adjustment by 1 every 0.2 seconds. The higher index was mean better traits ([Table 1](#t1-ajas-31-3-309){ref-type="table"}).

Sample preparation
------------------

Blood samples were collected from 99 domestic thoroughbred racehorses that had run a race at the Seoul Lets Run Park. To extract genomic DNA, 900 μL red blood cell (RBC) lysis solution was added to 300 μL of blood, processed for 3 minutes, and centrifuged at 15,000 rpm for 30 seconds. The supernatant was removed, and 300 μL of cell lysis solution and 100 μL of protein precipitation solution were added, and the solution was processed and mixed thoroughly. The DNA solution layer was collected by centrifuging the solution at 15,000 rpm for 5 minutes, and the supernatant was added to 300 μL isopropanol and shaken slowly. The resulting solution was centrifuged at 15,000 rpm for 10 minutes, and the supernatant was removed. And 500 μL of ethanol was added to the supernatant, and the solution was shaken until it became clear and then centrifuged at 15,000 rpm for 3 minutes. DNA was extracted by volatilizing and removing ethanol.

RNA extraction and cDNA synthesis
---------------------------------

Horse skeletal muscle tissue (50 to 100 g) was crushed with a mortar, and 3 mL whole blood was mixed with 9 mL RBC lysis buffer (Solgent, Daejeon, Korea) to remove RBC, where were dissolved using 1 mL Trizol (Invitrogen, Karlsruhe, Germany). Next, 200 μL chloroform was added to remove cells from organic solvent, and the mixture was shaken for 10 seconds and left at 4°C for 5 minutes and then centrifuged at 4°C for 15 minutes. The supernatant was removed and added to a new test tube, mixed with the same amount of isopropanol, and left at 4°C for 15 minutes to collect RNA pellets. Isopropanol was removed by centrifuging the solution at 4°C for 15 minutes, and it was sterilized with 85% ethanol and dissolved in RNase-Free Water. The purity of the extracted RNA was confirmed by measuring absorbance at 230 nm and 260 nm using a spectrophotometer (ND-100, Nanodrop Technologies Inc., Wilmington, DE, USA), and only RNA with a purity (optical density value of 230 nm/260 nm) greater than 1.8 was selected and stored at −70°C until the experiment was carried out.

To synthesize cDNA, 2 μg of RNA and 1 μL each of oligo-dT (Invitrogen, Waltham, MA, USA) and RNase-Free Water were added. The RNA was denatured at 80°C for 3 minutes, and cDNA was synthesized using 4 μL of 5× reverse transcription (RT) buffer, 5 μL of 2 mM dNTPs, 0.5 μL of RNase inhibitor (Promega, Madison, WI, USA), and 1 μL of Moloney-murine leukemia virus (M-MLV) reverse transcriptase (Promega, USA).

Polymerase chain reaction analysis
----------------------------------

NCBI (<http://www.ncbi.nlm.nih.gov>) and Ensembl Genome Browser ([www.ensembl.org](www.ensembl.org)) were utilized to retrieve gene sequence information. The primers used to detect SNPs were synthesized using PRIMER3 software (<http://bioinfo.ut.ee/primer3-0.4.0/>), and the synthesized primers included *ERRFI1* primers F (5′-AAGCTGTAGCAGCCCAGGTA-3′) and *ERRFI1* primers R (5′-TCCCAAGCTTTCACTTGAGG-3′). To determine the genotype of *ERRFI1* SNPs, polymerase chain reaction (PCR) was conducted on the genomic DNA of racehorses using the following conditions: initial denaturation at 94°C for 10 minutes; 40 cycles of denaturation at 94°C for 30 seconds, annealing at 58°C for 30 seconds, and extension at 72°C for 30 seconds; and final extension at 72°C for 10 minutes. PCR products were separated in a 1.5% SeaKem LE agarose gel (Lonza, Rockland, MA, USA), detected under UV light, and subjected to Sanger sequencing for confirmation after cloning. Cloning of PCR products was carried out using a pGEM-T Easy Cloning Vector System (Promega, USA), and each gene sequence was confirmed through Sanger sequencing. SNPs were checked by comparing the gene sequence obtained from sequencing with those obtained from a BLAST search (National Center for Biotechnology Information, Bethesda, MD, USA).

Real time-quantitative polymerase chain reaction amplification
--------------------------------------------------------------

The synthesized primers for quantitative PCR (qPCR) included *ERRFI1* primers F (5′-TGACCCAATAACCATGGCCT-3′) and R (5′-ATAATCAGAGGGGGCAAGCTG-3′). Real-time qPCR was carried out using a C1000 Thermal Cycler (Bio Rad, Hercules, CA, USA) to measure the relevant expression of target genes; 25 μL of reaction solution was used and the solution was constructed as follows: 2 μL diluted cDNA (50 ng/μL) was added to 14 μL SYBR green master mix (Bio Rad, USA), 1 μL each of 5 pmol/μL diluted forward and reverse primers. The conditions used for the real-time qPCR were as follows: initial denaturation at 94°C for 10 minutes followed by 40 cycles of denaturation at 94°C for 10 seconds, annealing at 60°C for 10 seconds, and extension at 72°C for 30 seconds. All measurements were carried out in triplicate for each specimen, and the 2^−ΔΔCt^ method was used to determine relative gene expression \[[@b20-ajas-31-3-309]\]. The relative expression of target genes was normalized with glyceraldehyde-3-phosphate dehydrogenase (*GAPDH*) \[[@b13-ajas-31-3-309]\].

Transcription factor binding site prediction
--------------------------------------------

Transcription factor binding sites were predicted using the ALGGEN PROMO software program v8.3 (<http://alggen.lsi.upc.es>).

Statistical analysis
--------------------

Allele frequencies for each genotype were derived from the observed distribution of the controls and were used to calculate expected genotype percentages. Observed genotype frequencies for the controls were compared to expected frequencies to test for Hardy-Weinberg equilibrium using a *x*^2^ test. Genotype and allele frequencies were determined by direct counting. A generalized linear model (GLM) was used to estimate the association of *ERRFI1* SNPs with race performance traits. The GLM was performed using SAS (version 9.3) with the three genotypes as independent variables and the racing traits as the dependent variable.

RESULTS AND DISCUSSION
======================

Expression of *ERRFI1* and *ERRFI1*-associated genes in horse
-------------------------------------------------------------

In our previous studies, we identified *ERRFI1* as a DEG in response to exercise and a selection signature gene related to the athletic adaptation of Thoroughbred muscle \[[@b14-ajas-31-3-309],[@b16-ajas-31-3-309]\]. In this study, we found a 1.6-fold increase of *ERRFI1* transcript after exercise compared to before exercise by qPCR ([Figure 1](#f1-ajas-31-3-309){ref-type="fig"}). To explain this expression pattern, 177 TF binding sites were predicted in the region defined by the *ERRFI1* gene to 600 bp upstream using PROMO (data not shown). When the predicted TF genes were matched to the DEGs, we found that the genes CCAAT/enhancer binding protein gamma, fli-1 proto-oncogene, ETS transcription factor (*FLI1*), hes family bHLH transcription factor 1 (*HES1*), interferon regulatory factor 1 (*IRF1*), junB proto-oncogene (*JUNB*), signal transducer and activator of transcription 4, and X-box binding protein 1 were upregulated, and forkhead box protein P3 (*FOXP3*), homeobox D8 (*HOXD8*), and peroxisome proliferator activated receptor gamma (*PPARG*) were downregulated ([Figure 2](#f2-ajas-31-3-309){ref-type="fig"}, [Table 2](#t2-ajas-31-3-309){ref-type="table"}).

Exercise stress causes inflammation due to immune responses, which are associated with the activation of pro-inflam-matory and anti-inflammatory pathways \[[@b14-ajas-31-3-309],[@b21-ajas-31-3-309]\]. Muscle injury caused by exercise is a well-known phenomenon that causes an inflammatory response \[[@b22-ajas-31-3-309],[@b23-ajas-31-3-309]\]. Cytokines comprise a variety of intercellular signaling proteins that affect target cells. Cytokines are signaling proteins that affect target cells that are related to cell migration, proliferation. Exercise-induced skeletal muscle damage causes acute inflammatory responses and activates the muscle fiber regeneration processes, and various cytokines can regulate *in vivo* muscle inflammation and muscle fiber regeneration \[[@b22-ajas-31-3-309]\].

The FOXP3 inhibits T helper cells' ability to function by directly inhibiting the activity of nuclear factor of activated T-cells and nuclear factor kappa-light-chain-enhancer of activated B cells which are important for cytokine gene expression and T cell function \[[@b24-ajas-31-3-309]\]. The pattern recognition receptor (PRR) recognizes pathogen-associated molecular patterns that cause inborn immune responses. The *IRF1* is involved in most PRR signaling events, given its immune activation capabilities that link innate and adaptive immunity \[[@b25-ajas-31-3-309],[@b26-ajas-31-3-309]\]. The *JUNB* is an immediate-early gene that regulates expression through a variety of extracellular stimuli. In addition, it plays a crucial role in cellular responses to given stimuli. The *FLI1* gene is an important regulator that modulates the expression of a variety of important cytokines. When *FLI1* expression inhibits endothelial cells, it reduces interleukin 6 (IL-6) production \[[@b27-ajas-31-3-309],[@b28-ajas-31-3-309]\], which is induced in muscle in response to exercise-induced stress in horses \[[@b14-ajas-31-3-309],[@b16-ajas-31-3-309]\]. IL-6 is not activated in resting muscles, but it is rapidly activated by muscle contraction and released from the muscles during exercise. The *JUNB* promoter is activated by the IL-6 response element \[[@b29-ajas-31-3-309],[@b30-ajas-31-3-309]\]. Finally, *ERRFI1* has been reported to be an important factor in the regulation of the stress response, maintenance of tissue homeostasis (such as in joints or heart muscle), and as a tumor suppressor \[[@b31-ajas-31-3-309]\]. Thus, we conclude that *ERRFI1* may be an important regulator of inflammatory responses caused by exercise.

Association analysis between candidate gene polymorphisms and racing traits of Thoroughbred horses
--------------------------------------------------------------------------------------------------

To evaluate horse *ERRFI1* as a genetic marker associated with racing traits, nsSNPs were screened from the coding regions of *ERRFI1* in the horse genome. As a result, an nsSNP was found in the 3rd exon (42830758th sequence of chromosome 2) where base changes from A to G caused an amino acid change from asparagine to aspartic acid at the 83rd amino acid ([Figures 3A, 3B](#f3-ajas-31-3-309){ref-type="fig"}). When DNA genotyping of the 99 Thoroughbreds was individually performed, 67 horses possessed the AA genotype, 29 the AG, and 3 the GG, and the allele frequencies were 81.5% and 17.5% for A and G, respectively. A Hardy-Weinberg equilibrium analysis was performed to compare genotyped (observed) to expected allele frequencies. An assumption of this method is that the alleles within each group are statistically independent, at least when no association exists, which is equivalent to assuming that the genotype frequencies in the general population comply with Hardy-Weinberg Equilibrium proportions. The result of the *x*^2^ test indicated a significant (\<0.01) difference between the expected and observed genotype frequencies meaning that the frequencies of all genotypes were in Hardy-Weinberg equilibrium ([Table 3](#t3-ajas-31-3-309){ref-type="table"}). The correlation between racing traits and *ERRFI1* genotypes was tested by GLM analysis, and we found that genotypes were significantly correlated with average prize money, average RI, Average speed and 3-year-old SPR. Horses with the AA genotype possessed high-scoring racing traits while individuals with the GG genotype had low-scoring racing traits. Individuals with the AG genotype had median racing trait values. Similarly, higher max speed, and 3-year-old RI were associated more closely with the AA genotype compared to others even if they were not significantly different ([Table 4](#t4-ajas-31-3-309){ref-type="table"}).

In conclusion, we proposed that the induction of *ERRFI1* and the regulation of inflammatory responses due to muscle damage in horses were correlated, and we subsequently found novel nsSNPs of horse *ERRFI1*. Further, we demonstrated the relationship between genotypes and racing traits, and the results from this study may contribute to the development of a genetic marker for the evaluation of racing performance and selective breeding.
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###### 

A summary of horse racing traits for the analyzed horses[1)](#tfn2-ajas-31-3-309){ref-type="table-fn"}

  Trait                          Max score     Min score   Mean±SD
  ------------------------------ ------------- ----------- -----------------
  Total number of entries        61            3           22.92±13.26
  Number of first arrival        14            0           2.6±2.64
  Number of second arrival       10            0           2.17±2.34
  Winning rate (%)               70            0           10.26±12.08
  Total prize money (in won)     604,150,000   0           118,258±126,196
  Average prize money (in won)   30,208        0           4,534±4,899
  Birth year                     2,007         2,001       2,005.48±1.37
   3-year-old RI                 5.7           0           1.12±1.27
   4-year-old RI                 8.23          0           1.23±1.48
   5-year-old up RI              6.1           0           0.86±1.14
   Average RI                    6.18          0           1.11±1.1
   3-year-old SPR                100           0           52.16±34.32
   4-year-old SPR                100           0           53.1±36.16
   5-year-old up SPR             100           0           49.78±41.15
  Average speed                  102           75          91.16±5.14
  Max speed                      121           83          104.55±8.89
  Average RI (\'09)              5.72          0           1.16±1.26
  Max SPR (\'09)                 100           0           58.55±40.17
  Average RI2 (\'09)             5.72          0           1.24±1.31
  Max SPR2 (\'09)                100           0           58.09±40.46

SD, standard deviation; won, Korean won; RI, racing index; SPR, starts percentile ranking.

Data were collected from the KRA (Korea Racing Authority) homepage (<http://studbook.kra.co.kr/studbook.jsp>).

###### 

List of predicted binding sequence locations and fold change values[1)](#tfn4-ajas-31-3-309){ref-type="table-fn"}

  Transcription factor   Binding sequence   Start position   End position   DEG (Fold change)
  ---------------------- ------------------ ---------------- -------------- -------------------
  CEBPG                  GGTTGTGCAA         240              249            0.94
                         TTGCTGAAAA         302              311            \-
  FLI1                   TGTGGGGT           29               36             0.59
                         TGTGGGGT           75               82             \-
                         TGTGCAGT           259              266            \-
                         GCTTCACA           563              570            \-
  FOXP3                  AAAATATTT          308              316            −0.54
                         AAAATTACT          343              351            \-
                         AAAATTAAG          404              412            \-
  HES1                   CTCCGTG            158              164            0.55
  HOXD8                  ATAAATG            16               22             −0.57
  IRF1                   TTTCCTCAT          491              499            2.64
  JUNB                   CTGTCA             250              255            5.15
  PPARG                  TGCTCTTTTAGC       131              142            −0.84
  STAT4                  GATTCC             292              297            1.11
                         GTTTCC             490              495            \-
                         GGAATG             528              533            \-
  XBP1                   ATGCTA             20               25             2.14
                         CGCCAT             176              181            \-
                         ATGAGC             198              203            \-
                         ATGCCT             356              361            \-
                         CCTCAT             494              499            \-
                         ATGAAA             531              536            \-
                         AGACAT             578              583            \-

DEGs, differentially expressed genes; CEBPG, CCAAT/enhancer binding protein gamma; FLI1, fli-1 proto-oncogene, ETS transcription factor; FOXP3, forkhead box protein P3; HES1, hes family bHLH Transcription Factor 1; HOXD8, homeobox D8; IRF1, interferon regulatory factor 1; JUNB, JunB proto-oncogene; PPARG, peroxisome proliferator activated receptor gamma; XBP1, X-box binding protein 1.

DEGs were extracted through whole transcriptome analyses of Thoroughbred horses before and after exercise.

###### 

Chi-squared and Hardy-Weinberg equilibrium testing of SNP-type distributions for SNPs (LOC42830758 A to G) of the *ERRFI1* gene

  \% (No.)   Overall    Genotype     Allele frequency   χ^2^                       
  ---------- ---------- ------------ ------------------ ---------- ------- ------- ----------
  Observed   100 (99)   67.68 (67)   29.29 (29)         3.03 (3)   82.33   17.67   0.004164
  Expected   \-         67.78        29.10              3.12       \-      \-      \-

SNPs, single-nucleotide polymorphisms; *ERRFI1*, ERBB receptor feedback inhibitor 1.

###### 

Association test between novel nsSNPs of the ERRFI1 gene and horse racing traits[1)](#tfn7-ajas-31-3-309){ref-type="table-fn"}

                           AA                          AG                           GG
  ------------------------ --------------------------- ---------------------------- -----------------------------
  Average money (in won)   6,543,395.7±854,210.92^a^   4,280,780.7±1,074,743.9^b^   3,330,945.7±2,835,321.6^ab^
  Average RI               1.73±0.19^a^                1.19±0.24^b^                 1.09±0.64^ab^
  Average speed            94.62±0.82^a^               91.97±1.03^b^                93.68±2.71^ab^
  MAX speed                110.86±1.32                 107.68±1.66                  106.64±4.38
  3-year-old RI            1.57±0.25                   1.01±0.32                    0.62±1.39
  3-year-old SPR           71.34±5.58^a^               54.51±7.16^b^                57.16±31.31^ab^

nsSNPs, non-synonymous single-nucleotide polymorphisms; *ERRFI1*, ERBB receptor feedback inhibitor 1; RI, racing index; SPR, starts percentile rank.

Bolded values indicate a significant association between the novel nsSNP genotype and the racing trait.
